Search Results - I Parodis
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
PO.6.120 Non-pharmacological management of systemic lupus erythematosus and systemic sclerosis: a systematic literature review to inform eular recommendations by D Pezzella, A Gómez, T Stamm, I Parodis, JW Chow, A Tsoi, C Girard, C Boström
Published in Lupus Science and Medicine (2022-10-01)Article -
5
PO.7.146 Sensitivity analysis of EQ-5D-3L index scores in relation to discriminative and known-groups validity in systemic lupus erythematosus by A Gómez, J Lindblom, I Parodis, N Hua, G Von Perner, Y Enman, M Regardt, E Heintz, S Emamikia, D Grannas
Published in Lupus Science and Medicine (2022-10-01)Article -
6
PO.7.149 Associations between abnormal bmi and patient-reported health-related quality of life before and after therapeutic intervention in patients with systemic lupus erythematos... by A Borg, A Gómez, J Lindblom, I Parodis, A Soltani, G Von Perner, Y Enman, M Regardt, E Heintz, S Emamikia, D Grannas
Published in Lupus Science and Medicine (2022-10-01)Article -
7
PO.5.99 Drug repurposing for treating lupus nephritis based on transcriptome profiling and autoimmunity-related serological markers by J Lindblom, MO Borghi, M Alarcón-Riquelme, C Mohan, J Castillo, G Barturen, I Parodis, Y Enman, E Carnero-Montoro, D Toro-Domínguez, D Repsilber
Published in Lupus Science and Medicine (2022-10-01)Article
